Muscular Dystrophy Association, INC.

Based in IL

🤖

AI Overview

With $3.5M in lobbying spend across 34 quarterly filings, Muscular Dystrophy Association, INC is a significant lobbying presence. Their lobbying covers 22 issue areas. Active from 2018 to 2025.

$3.5M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$160K
2019	$230K
2020	$400K
2021	$400K
2022	$720K
2023	$840K
2024	$370K
2025	$420K

Lobbying Firms

Muscular Dystrophy Association, INC.

Lobbyists

Kristin Stephenson Brittany Hernandez Paul Melmeyer Marc Gottschalk Michael Lewis Joel Cartner Shannon Wood

Government Agencies Targeted

These are the government entities that Muscular Dystrophy Association, INC. disclosed contacting in their lobbying filings.

Executive Office of the President (EOP)Federal Aviation Administration (FAA)Food & Drug Administration (FDA)HOUSE OF REPRESENTATIVESNatl Institutes of Health (NIH)SENATETransportation, Dept of (DOT)Centers For Medicare and Medicaid Services (CMS)Office of Management & Budget (OMB)Centers For Disease Control & Prevention (CDC)Health & Human Services, Dept of (HHS)Labor, Dept of (DOL)Natl Institute of Standards & Technology (NIST)Treasury, Dept ofHealth Resources & Services Administration (HRSA)Natl Council on DisabilityEducation, Dept ofSocial Security Administration (SSA)Defense, Dept of (DOD)Transportation Security Administration (TSA)+10 more

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Aviation, MED, Medicare/Medicaid and 17 more

Health care issues affecting individuals with neuromuscular disease, including therapy development and newborn screening.

Health care reform including H.R. 750 - Ensuring Access to Quality Complex Re

FDA funding contained in H.R.3268/S. 1603 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2018; research funding for NIH and newborn scree

Implementation of the Air Carrier Access Act (ACAA); S. 1318/H.R. 5004 - Air Carrier Access Amendments Act of 2017; H.R. 2997 - 21st Century Aviation Innovation Reform and Reauthorization Act; S. 1405

FDA funding contained in H.R.5961/S. 2976 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY2019; research funding for NIH and newborn scree